5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition-Reference-Cited by-同舟云学术

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

Published:2002-04 Issue:7 Volume:12 Page:1099-1102
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Auberson Yves P,Allgeier Hans,Bischoff Serge,Lingenhoehl Kurt,Moretti Robert,Schmutz Markus

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference15 articles.

1. See, for example: (a) Herrling, P. L.; Emre, M.; Watkins, J. C. In Excitatory Amino Acids: Clinical Results with Antagonists; P. L. Herrling, Ed.; Academic: London, 1997; pp 7 and 129.

2. 5-aminomethylquinoxaline-2,3-diones. Part I: A novel class of AMPA receptor antagonists

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2-BFI protects against ischemic stroke by selectively acting on NR2B-containing NMDA receptors;2023-07-05

2. Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry;Neuropsychopharmacology;2023-06-27

3. Cognitive Flexibility in Mice: Effects of Puberty and Role of NMDA Receptor Subunits;Cells;2023-04-22

4. Changes in NMDA Receptor Function in Rapid Ischemic Tolerance: A Potential Role for Tri-Heteromeric NMDA Receptors;Biomolecules;2022-09-01

5. NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous System;International Journal of Molecular Sciences;2022-08-09